How do oncogenes co-opt SWI/SNF function to drive transformation in neural tissues?

OPEN

The abstract mentions oncogenes co-opting SWI/SNF function for transformation but provides no mechanistic details. This gap is particularly relevant for understanding brain tumors and neural transformation processes. Gap type: unexplained_observation Source paper: Chromatin remodellers as therapeutic targets. (2024, Nature reviews. Drug discovery, PMID:39014081)

Priority: 0.74 Domain: neuro-oncology Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How do oncogenes co-opt SWI/SNF function to drive transformation in neural tissues? is a 0.74 priority gap in neuro-oncology. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How do oncogenes co-opt SWI/SNF function to drive transformation in neural tissues? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (44)

BECN1SNFASCSWICLDN2SNFBRG1SWICLDN2SWI
▸ Show 39 more

causes (1)

SNFcancer

data in (4)

benchmark_ot_ad_answer_key:SWISWISWIbenchmark_ot_ad_answer_key:SWIbenchmark_ot_ad_answer_key:SNFSNFSNFbenchmark_ot_ad_answer_key:SNF

interacts with (1)

SNFSWI
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps